Cambridge, MA, United States of America

Erica Kahn

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 9.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Erica Kahn: Pioneering Ocular Treatments

Introduction: Erica Kahn is a distinguished inventor based in Cambridge, MA, with a remarkable contribution to the field of ocular treatments. With a portfolio of two patents, her work is at the forefront of innovative medical solutions aimed at enhancing patient care in retinal disease treatment.

Latest Patents: Erica's latest patents focus on the development of a sustained-release biodegradable ocular implant featuring a tyrosine kinase inhibitor. The first patent, titled "Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor," outlines innovative methods using this implant for effective and prolonged treatment outcomes. Her second patent, "Ocular implant containing a tyrosine kinase inhibitor," further refines this concept, illustrating a device designed for the extended treatment of retinal diseases through the sustained release of the therapeutic agent embedded within a hydrogel.

Career Highlights: As an inventor at Ocular Therapeutix, Inc., Erica has leveraged her expertise to develop groundbreaking technologies in ocular health. Her work plays a critical role in advancing therapeutic options for conditions that have previously posed significant challenges in treatment efficacy.

Collaborations: Throughout her career, Erica has collaborated with esteemed professionals, including colleagues such as Charles D. Blizzard and Arthur Driscoll. These partnerships have not only enriched her projects but have also led to innovative multidisciplinary approaches in the field of ocular treatment.

Conclusion: Erica Kahn's contributions to the field of ocular innovation underscore her dedication to improving patient outcomes through inventive solutions. With patents that represent significant advancements in treatment methodologies, she continues to inspire fellow inventors and the medical community alike. Her journey is a testament to the impact of innovation in healthcare, paving the way for future breakthroughs in retinal disease management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…